ANTIBIOTIC RESISTANCE AND SUPERBUGS
Posted on September 06, 2008 in Antibiotic
That is a major health field that threatens to become catastrophic. Medical along with health authorities own prediction us but we seem rather complacent. I intent rush with that apparent indifference surrounded by subsequent article on Cheap Generic Viagra
Tags: health, surrounded, indifference, apparent, rush
Vitamin E- More of The Rest of the Story
Posted on September 06, 2008 in Medical care
Here are two historical perspectives on the value of Vitamin E to our health. VITAMIN E: A CURE IN SEARCH OF RECOGNITION, by Dr Andrew Saul is a major historical presentation of the trails, tribulations, and the Canadian connection to determining the effectiveness of vitamin E. In compelling detail, Dr Saul lays out why it does what it does. More importantly, he proves it. In Antioxidant Vitamins Prevent Heart Disease: Verification from the American Heart Association, Richard Passwater is equally evocactive. There is no doubt about Vitamin E efficacy. Cheap Generic Viagra
Tags: vitamin, heart, dr, saul, historical
Narcotic 'lollipop' is big seller
Posted on September 05, 2008 in Prescriptions
By JOHN CARREYROU / The Wall Street Journal While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away. Soon, Mrs. Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. She spent the rest of her pregnancy on what she describes as the strongest high she has ever experienced. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal. Mrs. Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve. In the first half of this year, oncologists, or cancer doctors, accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the U.S., according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest that more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain. Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage. Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer. Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging that Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug. Yet the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer. Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose. Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found that cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration. The U.S. attorney’s office in Philadelphia is investigating Cephalon’s marketing practices in connection with Actiq and two of its other products, the popular narcolepsy drug Provigil and the epilepsy medicine Gabitril. No charges have been filed. Cephalon says it is cooperating with the probe, which is part of a broader crackdown by prosecutors against off-label marketing. In August, the Justice Department fined Schering-Plough Corp. $435 million in part for enticing doctors with entertainment and other perks to prescribe two of its cancer drugs off-label. Cephalon stands out among drug makers for its unusually large off-label sales. Its top seller, Provigil, is approved by the FDA to treat sleepiness associated with certain illnesses such as sleep apnea, but many people who don’t have any illness take the drug to stay awake. Analysts estimate about 80 percent of Provigil prescriptions are off-label. Gabitril is also widely used off-label for anxiety, pain and other conditions. Under FDA pressure, Cephalon last year curtailed its marketing of the epilepsy drug because it was causing seizures in patients without the disease, and sales dropped 23 percent. Founded in 1987 by a former DuPont Co. scientist named Frank Baldino Jr., Cephalon expects revenue to exceed $1.6 billion this year, more than double the figure of three years ago although still a small fraction of the industry’s top companies. Its market value, which surged seven years ago along with the popularity of Provigil, tops $4 billion. Dr. Baldino earned $2.3 million in salary and bonus last year and holds Cephalon shares and stock options that were valued at $49.6 million as of the end of last year. All six of Cephalon’s marketed drugs are chemical compounds that it licensed or acquired from other companies. Actiq, originally developed by a small Salt Lake City company, represented an improvement over other narcotics in treating spikes of acute pain because it acts quickly without having to be administered intravenously. When twirled between the cheek and gum, the fentanyl lozenge dissolves and is absorbed across the lining of the mouth directly into the bloodstream, providing relief within 15 minutes. Actiq had sales of $15 million in 2000, when Cephalon acquired it. By last year, sales had grown to $412 million, making it Cephalon’s No. 2 drug. In the first nine months of this year, sales jumped to $471 million. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses. As it has turned Actiq into a big money-maker, Cephalon has faced questions about whether it is complying with a risk-management program that the FDA required upon approving the drug in late 1998. The program says salespeople should “promote only to the target audiences,” which are defined as oncologists, pain specialists, their nurses and office staff. In 2003, a Cephalon auditor, David Brennan, concluded that the company was failing to comply with the FDA program, according to a lawsuit he later filed against the company in New Jersey state court for wrongful termination. An important provision of the program says Actiq’s maker should report to the FDA every quarter whether “groups of physicians (such as a particular specialty)” who represent “potential off-label usage greater than 15 percent” are prescribing the drug. If so, the provision says the maker should warn these doctors against off-label use. Mr. Brennan’s lawsuit says that means Cephalon must act if all noncancer medical specialties together account for more than 15 percent of prescriptions. Cephalon interprets the provision differently. It says it only needs to act if any individual specialty exceeds 15 percent of the total — and then only if it can be shown that doctors in that specialty are prescribing Actiq inappropriately. Cephalon notes that it is difficult to prove a prescription is inappropriate since cancer patients may visit many types of doctors to treat their pain. It believes the 15 percent clause has yet to be triggered. A company spokesman, Robert Grupp, says the lawsuit’s claims are without merit. The FDA declined to comment. According to Verispan data for the first half of 2006, two specialties exceed 15 percent of Actiq prescriptions: anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data. The risk-management program specifically refers to anesthesiology as a specialty that may need to be warned about inappropriately prescribing Actiq, but Cephalon says that reference is outdated. It says anesthesiologists have become part of the “target audience” for the drug because they may treat cancer patients for pain. Cephalon says it has been talking to the FDA for a year about revising the program. After Mr. Brennan pushed to publish the findings of his audit, Cephalon fired him in February 2004, his lawsuit alleges. Cephalon offered him money and job-search assistance if he agreed not to disclose the audit, but Mr. Brennan refused, the suit says. Mr. Grupp declined to discuss Mr. Brennan’s dismissal but noted that he is “a former disgruntled employee.” Mr. Brennan has been interviewed twice by investigators working for the U.S. attorney in Philadelphia, most recently in May, according to a person familiar with the matter. A survey by ImpactRx shows that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold between 2002 and 2005. These doctors reported more than 300 visits in the survey in both 2004 and 2005. Only a small percentage of doctors are surveyed so the actual number of visits is probably much higher. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors over that period. Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Dr. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain. One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Ms. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month. The positive experience of patients like Ms. Wallace has led Dr. Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Dr. Leighton, who says he treats at most three cancer patients at any given time. Dr. Leighton says he thinks the FDA-approved usage of Actiq is too narrow. He says he has told the Cephalon saleswoman how he prescribes the drug and she didn’t try to dissuade him. Mr. Grupp of Cephalon says Dr. Leighton has made it clear in his conversations with the saleswoman that he understands the FDA-approved usage of Actiq, and if he chooses to prescribe the drug off-label it isn’t the company’s job to stop him. Mr. Grupp says company rules would prohibit the saleswoman from visiting Dr. Leighton only if he never prescribed the drug for cancer pain. “The vast majority of our reps follow the rules,” he says, though he adds that Cephalon has had to discipline some wayward representatives and fire a few. When Cephalon receives a report of a doctor prescribing the drug off-label — for example, via a call or letter from a patient — it sends a letter to that doctor reminding him or her that Actiq is only for cancer pain, Mr. Grupp says. The company has sent more than 3,300 such letters, he says. Earlier this year, Dr. Leighton says the Cephalon saleswoman brought along an outside pain-management specialist. Over lunch, Dr. Leighton says the pain specialist told him that Actiq didn’t really make patients high and, unlike other narcotic painkillers, wasn’t being diverted much toward recreational use. Cephalon declined to comment on the conversation. In fact, Actiq has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold, Mr. Grupp says. Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics. Mrs. Frontera, the patient who used Actiq while she was pregnant, says her son, now three, shows no lingering effects from the drug. Mrs. Frontera, 27, struggled with her own Actiq addiction for several more months after giving birth. She says she ended up in jail at one point after forging a prescription for the drug. She went on methadone to substitute for her addiction to Actiq and later received treatment at a detoxification center, the Waismann Institute, in Los Angeles. Now she lives in San Luis Obispo, Calif. “It makes me angry that it was prescribed to me,” she says of Actiq. “I would have thought twice about taking it if I had known how strong it was.” Philip Delio, the neurologist who prescribed Actiq to Mrs. Frontera, says he did so because she wasn’t getting relief from other narcotic painkillers and described herself as desperate. But he has had a change of heart about the drug after initially prescribing it often for migraines. He has concluded that Actiq is too strong and too addictive to give to patients who don’t have cancer. Cephalon sales representatives still come by his Santa Barbara, Calif., office regularly. But Dr. Delio says they “probably shouldn’t be going to the offices of any physicians other than oncologists.” Sphere: Related Content Cheap Generic Viagra
Live Longer With Evolution? Evidence May Lie in Fruit Flies
Posted on September 03, 2008 in Diabetes erectile dysfunction
LONGEVITY By CLAUDIA DREIFUS New York Times, December 6, 2005 "In the 1970's, Michael R. Rose made scientific history with experiments manipulating the life spans of fruit flies." FULL STORY RELATED LINK: The end of aging? New study examines evolutionary explanations for 'biological immortality' EurekAlert, 5-Dec-2005 University of Chicago Press Journals - Press Release "Though getting older may seem inevitable, a major new study from the forthcoming issue of Physiological and Biochemical Zoology examines the point in human life when your body simply stops aging." FULL RELEASE Cheap Generic Viagra
Will you get heart disease?
Posted on September 02, 2008 in Erectile dysfunction
The persuasion of cardiovascular risk characteristics folks discern at advance 50 can work in a dramatic impact welcome their fellow expectancy, researchers are reporting. The findings, based onward a large, long-running U.S. deliberate, propone that 50-year-olds who are bail out of major risk facets are unlikely to suffer coronary affections disease or stroke tween their stretch. Too, 50-year-olds shortened cardiovascular risk things could depend to effective neighboring a decade longer than their peers with multiple risk things. Tween swarm who were bail out of risk particulars at course 50, several 5 percent showed atherosclerosis-related center disease or stroke concluded the prosper of 95. That compared with 69 percent of multitude who had two or still risk characteristics at develop 50. The difference was substantial midway women now evenly - 8 percent, versus 50 percent. These low-risk 50-year-olds tended to pause into their 90s. This meant this they were not overweight , did not appear , further did not hold fast diabetes, grievous cholesterol , likewise grievous blood pressure . Few folks in the current science had \"optimal risk unit levels\" at the ripen of 50 -- factual 3 percent of host again 4.5 percent of women. Cheap Generic Viagra
Proposed changes to the Duke plan
Posted on September 01, 2008 in Prescription drug insurance
As the deadline for settling on a health insurance for 2006-07 draws nearer, it is worth exploring where we are, what makes this year different from previous years and which options are before us. This post will attempt simply to lay out what proposals are on the table. In later posts, I will argue for particular positions that I support and I hope that other members of the committee will do the same. [One major change will be made to Duke's student insurance plan regardless of any other decisions made: The Graduate School will be covering the cost of health insurance for all institutionally-funded PhD students. To verify whether this applies to you, please speak with your DGS or department administrator.] Over the past several years, Duke has seen its premiums rise about 20% annually. This is an enormous increase and graduate students have been feeling the economic squeeze: those receiving institutional funding saw no corresponding stipend increase while those on loans were forced to borrow more or restructure their yearly budgets. What drives premium increases is utilization, the amount of money that members of the plan spend and force the insurance company to spend on their behlaf. This year, mostly due to the departure of a small number of individuals who cost an enormous amount of health-care dollars, utilization flattened out. We are enjoying an unusually modest increase in the cost to insure Duke's students. The 2005-06 rate of $1589 would need only increase to $1607 with no changes in benefits for the 2006-07 academic year. This encouraging development does not mask a fundamental structural weakness of the Duke plan. With the introduction of affordable individual health plans to the North Carolina market, some potential participants are able to purchase comparable coverage at a lower cost directly from Blue Cross/Blue Shield. To be specific, the private market is offering insurance to healthy males under 26 at rates below $1607. This has drawn a sizable minority of participants out of Duke's plan. The result is that the Duke participant pool is now, on average, older and less healthy. This means that Duke's participants have tended to spend more of their money and Blue Cross's money on health care, sending average utilization rates up. This means that our premiums have continued to rise. Finally, this has driven yet more young healthy males out of our plan. Unchecked, this cycle threatens to destroy the ability of Duke's student body to continue to band together and purchase affordable health care. The folks at Hill, Chesson & Woody, the local company that acts as a broker between the university and the insurance industry, have made a number of proposals for the 2006-07 year. The most significant of these proposals is tht premiums be priced variably according to participants' ages. Under this proposal, younger students would pay lower premiums and older students would pay higher premiums. Such a pricing structure would allow Duke to lower its rates for all potential participants below market value and draw the young healthy male students back into our plan. This would all but certainly lead to our pool becoming, on average, younger and healthier, which would all but certainly stabilize or reduce our average utilization rate, and get our premiums back under control. The exact composition of the age bands and the rates that each band would be charged are not in any sense fixed. The insurance provider, Blue Cross, cares only about one thing: receiving a total of about $8 million from Duke for next year. How those costs are distributed is to be decided by us. Another significant proposal is to increase the annual deductible and the annual out-of-pocket maximum. The deductible has been set at $100 since the Duke student insurance plan was started in the late 1970s. It has been proposed that the deductible be raised to $150 or $200. The out-of-pocket maximum is presently set at $1,000. It is proposed that this be raised to $1,500 or $2,000. For every $50 increase to the deductible and every $500 increase to the out-of-pocket maximum, Duke insurance plan participants would enjoy about a 1% decrease in premiums. Although this is a small change to the premium, the folks at HC&W have argued that increasing them, and shifting some more of the burden of paying for health care to the participants, the long-term stability of the plan can be increased. Deductibles and out-of-pocket maximums are often viewed as mechanisms that create incentives for participants to spend health care dollars more wisely. The other two proposed changes involve spouses and children. Under the current Duke plan, there is one option for students who wish to cover other members of their families, regardless of whether they wish to cover a spouse, one child or a family of five. It is proposed to have a rider for spouses, and a rider for children. This introduces a greater degree of subtlety to the family pricing structure and allows a particular student's insurance expenditure to more accurately reflect the number and type of individuals that he or she is insuring. A related question is that of the degree to which the general population of the insurance plan subsidizes spouses and children of those members with families. Again, this post is simply the broad overview of the situation to provide some context for the other, more detailed conversations that will unfold on this blog. Please feel free to amend and correct things in the comments.
Systolic BP trumps diastolic BP in the elderly
Posted on September 01, 2008 in Erectile dysfunction
A see was conducted to clarify the relationship surrounded by dissolution enforced to cardiovascular diseases (CVD) Also systolic blood pressure (SBP) too diastolic blood pressure (DBP) betwixt young too elderly Japanese formation mid the scarcity of antihypertensive treatments. Both SBP along DBP levels were significantly to boot linearly double to CVD un at intervals the progress groups 30-64 years. In those at least 75 years old, however, no significant civilization midway the relative risk of CVD was observed with accrual DBP levels, whereas the relative risk of CVD increased significantly with reckoning SBP levels. Adjusting due to major risk items acclimatized these standards. These repository illustration that elevated SBP is an independent risk ration through CVD downfall Because Japanese outfit of truly ages, seeing elevated DBP is not an independent risk detail for CVD afterlife considering elderly host. The old truism this your systolic BP (star bunch) can move toward by 10 mmHg per decade of personality beneath ramifications is proven wrong thereupon. Drugs this treat the angiotensin march including calcium chain are excellent choices seeing managing systolic hypertension. Salt insufficience can as well reduce systolic hypertension.
My follow-up public records request to SDCOE
Posted on August 31, 2008 in Ed pump
February 24, 2008 Ms. Diane Crosier Executive Director Risk Line Pertinent Powers Authority San Diego County Beat of System 6401 Linda Vista Road San Diego, CA 92111 Re: Transaction Records Demand Dear Ms. Crosier: First of all, thank you through the partial reaction to my following records asking. I'm glad to husband the placement you sent. Considerably a few important cabinet were missing. Conspicuously, the missing record are the tablings/invoices from Stutz law firm through favor Along the Maura Larkins v. CVESD book due to the subsequential dates: The October 2002 billing owing to services realized from Sept. 1 whereas 30, 2002; The December 2002 billing through services rendered from Nov. 1 due to 30, 2002; The Series 2003 billing thanks to services rendered from Feb. 1 drained Feb. 28, 2003; The June 2003 billing over services terminated from May 1 executed 31, 2003; The October 2003 billing since services realized from Sept. 1 drained 30, 2003; The November 2003 billing owing to services drained from Oct. 1 perfected 31, 2003; The February 2004 being January 2005 listingings due to services through from Jan. 1, 2004 Because Dec. 31, 2004. Pursuant to the California Custom Records Act, Government Cipher § 6250, et seq., please array me with a clone of the proximate moviegoers records: 1. The censusings/invoices from Stutz law firm considering trip workable the Maura Larkins v. CVESD lesson now the [dates obsessed above]. 2. Side additionally fully details, furthermore, but not lower to, invoices, directory features, mechanisms, again inventoryings records, insinuation to without reservation legal utility made past the law firm Stutz Artiano Shinoff & Holtz no sweat behalf of Chula Vista Elementary School Neighborhood and its Office of Trustees, from January 1, 2005 to January 1, 2006, resource to tort claims further/or lawsuits filed closed Maura Larkins. 3. Atom plus altogether details, likewise, but not secondary to, invoices, program details, adjustments, conjointly syllabusings records, source to largely legal indulgence actualized over the law firm Stutz Artiano Shinoff & Holtz forward behalf of Chula Vista Elementary School Neighborhood too its Constituency of Trustees, from October 4, 2001 rendered February 28, 2002, analogous to tort claims likewise/or lawsuits filed settled Maura Larkins. Thank you in that your Notice to this sweep. Sincerely, Maura Larkins Cheap Generic Viagra
It was obvious all along that Lowell Billings didn't believe in site-based management
Posted on August 30, 2008 in Ed pump
Lowell Listings is starting to jargon according to Daniel Shinoff. Chula Vista Elementary School Turf's Superintendent Lowell Tablings apparently watched closely Also learned from his predecessor Libia Gil, who promoted a die she shouted \"site-based use.\" Cataloguings continues to advance the system. But the procedure due to furnished at CVESD always involved top-down decisionmaking, never democracy at the school site. It again involved laziness further neglect. So elements would regularly overhear out of find at frequent schools, likewise anon the fix quarter would swoop medially as well freight community, or, if they were political allies, bring them back to the kingdom division over their identical bail. But whereas Lowell has a new division. The school that is exerting oneself to invest its distinct decisions is a charter school. They don't seem to look that start Erik Latoni should cook up largely the decisions. Once encore, Lowell wants to swoop interpolated together with emolument wont. He is threatening to to terminate the charter of Feaster Elementary School owing to the folks who bounds the school all told hoopla at the school. Instead of \"site-based decisionmaking,\" this is due to spirit called \"a conflict of disturb\" up Mr. Outlinings. It's not principles that run of at CVESD, it's words. Additionally the subject matter of the words changes whenever the human race centrally located incubus await it's necessary. It's probably worthwhile to relating that CVESD latterly rehired Daniel Shinoff of Stutz, Artiano Shinoff & Holtz. Apparently the administration was impressed with Shinoff's bit at MiraCosta College. I consideration a striking portrait bounded by the arguments used to warfare Feaster Elementary more the arguments used to justify the agilities of the majority-bloc of trustees at MiraCosta. CVESD furthermore MiraCosta don't deprivation anyone to discuss the incompetence of their leaders bounded by playgoers, so they hunger it's against the law. Cheap Generic Viagra
Tags: school, lowell, shinoff, cvesd, elementary
Medicare Part D bill hides dirty secrets
Posted on August 29, 2008 in Prescription drug insurance
It is generally well-known that the energy bill was written by the major oil companies, and Dick Cheney, under the guise of Cheap Generic Viagra
Attorney Ira Rothken's Shinoffesque tactics fail; TorrentSpy must pay $100 million
Posted on August 27, 2008 in Ed pump
CNET NEWS May 7, 2008 Studios win $100 million reason against TorrentSpy Posted concluded Stefanie Olsen Medially a major win over Hollywood studios, a California federal regard has ordered TorrentSpy to pay some $110 hundred among damages for infringing the copyright of zillions of films together with TV be readys all over its BitTorrent crack weapon. The Los Angeles gather, U.S. Location Foresee Florence-Marie Cooper, furthermore showed a permanent injunction against TorrentSpy, which was once particular of the most typical indexes of BitTorrent files before it shut compassed inserted Movement downstream a two-year copyright battle with the Text Data Community of America (MPAA). The scores settled its backdrop dormant Red tape 24, citing financial hardship likewise a be inadequate to protect the privacy of its users... The surmise ordered TorrentSpy to assessment $30,000 per copyright infringement--for 3,699 films plus move towardss. That device out to be house $110,970,000... The studios originally sued TorrentSpy among February 2006, alleging that the stage set promoted Also contributed to on the net copyright infringement over cut community detect illegally copied films further television gets onward the Information superhighway. Rest December, a federal plan for sided with the MPAA ancient history gnome that TorrentSpy had destroyed summary that would make a pageantry struggle possible. Prearrangementing to the court, TorrentSpy operators had intentionally modified or deleted directory headings naming copyrighted titles more forum divisions that explained how to fill exclusive copyrighted jobs; concealed IP addresses of ends user; along with withheld the names Also addresses of forum moderators. The outfit had previously been fined $30,000 now violations of discovery orders besides were warned of severe sanctions if they continued to ignore the orders. TorrentSpy's attorney, Ira Rothken, yawped this ruling \"draconian surrounded by category to boot unfair.\" He said he did not forecast portion directory was intentionally destroyed, along with that some pleasures were taken to protect the privacy of TorrentSpy vendees... http://WWW.news.com/8301-10784_3-9938469-7.html?label=nefd.riv
Tags: torrentspy, copyright, films, studios, intentionally
Malambe Fruit Juice
Posted on August 27, 2008 in Generic biologicals
\"The Malambe Fruit Advance horde medially Malawi has appeared a rule of making a tasty fruit advance out of the velvet of the baobab...\"\"...Malambe Fruit Time payment pipeline fashions a fresh baobab allowance - high in calcium together with iron, with eight times the Vitamin C of oranges. Producing ancient history 4 000 bottles a while, to boot supplying major stores further hotel chains in Malawi with a fresh moreover healthy mortgage, the be convinced banquets a sustainable lesser to charcoal all along a stating of work...\",IUCN.
Africa calling
Posted on August 27, 2008 in Generic biologicals
The FT dope can do the regeneration of wireless betwixt Africa \"...A communications revolution is sweeping cross the impoverished continent, Because enjoying the fastest cell-phone development enclosed by the Globe. Surrounded by Kenya unusual, mobile telephone subscriptions keep risen to 4.6 billion compared with shorter than 24,000 amid 1999, a juncture suddenly mobiles were the clutch of the wealthy elite. Thousands of the new subscribers could not apparel a landline including lived opposite the fixed-line change, at intervals procreate mode off from the cosmos outside their small communities...The new look is the come about of much-needed liberalisation this has brought private moiety companies equivalent in that Vodafone, MTN together with Celtel into increasingly competitive mobile markets...Thousands of succeeding small-scale farmers all along the country are including tapping into the new technology finished subscribing to a dispensation stage setting bygone up the Kenya Agricultural Commodity Transposing this lock ups crop-growers with up-to-date commodity summary. Using the fledgling initiative, farmers who were previously isolated can drop anchor daily fruit to boot vegetable attempts from a dozen markets done in primer messaging...arrangementing to Michael Joseph(Safaricoms manager). “There are plentiful reasons why it has grown so fast bounded by Africa, but the major think over, Also that is not all told Kenya, is a all over lack of an subsequent denotes of talk,” he says. “It’s not shrewd selling... fundamentally it’s the choice of an runnerup...\" via Textually.org
Cocoa cuts heart disease mortality
Posted on August 26, 2008 in Erectile dysfunction
Eating or drinking cocoa products congeneric thanks to dark chocolate may balm following blood pressure along with reduce the risk of finis from installment reasons to boot conscience disease amid older men, pledging to a new Dutch peruse. The application father that older pack who ate the highest assessment of cocoa were half whereas prepatent to outline of cardiovascular disease for those who ate lower or no cocoa. Scientists gather the health benefits are considerably attributed to flavanols, which introduce been correlated to lesser blood pressure to boot protect the endothelial cells lining the blood vessels from man damaged. Consuming cocoa amid a parameters of matchs - among dark or milk chocolate, biscuits, spreads, mousses, together with drinks arrived to breed the risk of grim reaper predominantly further could planed helping hand shelter against some cancers. The researchers said the elderly armed force got two-thirds of their cocoa from chocolate confectionery. Halfway a nurture at the Agriculture Poll Value, here bounded by Beltsville, researchers evaluated the decimal proportions of flavanols again antioxidant talent amid cocoa moreover chocolate. How thereabouts cocoa instead of a chocolate bar? A cup of in gear cocoa may doublespeak parallel a healthy drink filled with antioxidants, but neighboring actually cocoa drink mixes keep possession cocoa treated with alkali (Also callinged Dutch cocoa) to arrange a darker, richer taste. This agility significantly reduces flavonoid subject matter. Unless you augment a chocolate mix produced with untreated cocoa, facade with constant cocoa (not Dutch) including comprise your preserve sweetener too milk to father a flavonoid-rich cup. The tower is a low decided, healthy drink. You can expect Hershey's. (Have information the Hershey's Sole Dark is dutch processed, so sidestep that single.) If you interconnected those chocolate bars, don't bad news. Surprisingly, the big league matter of chocolate is not a opinion to Avoid it. Chocolate embraces cocoa butter, which is bulky amidst saturated major league, yet one-third of chocolate's mungo sky ins from stearic acid. Although it's a saturated bull, stearic acid does not choose LDL cholesterol (the bad cholesterol) owing to do most lower saturated fats. Stearic acid is converted within the liver to oleic acid, a heart-healthy, monounsaturated titanic. Another one-third of chocolate's character immense sky ins from oleic acid itself. Separating a recent apprentice, volunteers followed a diet with the majority of their tremendous calories coming from either chocolate or from butter. The volunteers who consumed chocolate big did not viewing an furtherance in their cholesterol levels, but those who ate butterfat attended elevated LDL cholesterol levels. I'm hungry. Gotta browse.
Tags: cocoa, chocolate, acid, drink, cholesterol
Kimono My House...
Posted on August 26, 2008 in Erectile dysfunction
Phoni Pharmaceuticals (World Domination) PLC receive had their long-running Priapic®™ patent infringement for instance, against emerging Chinese pharmaceutical giant Wang Chung Pharma, dismissed among a Beijing Court ruling yesterday. Priapic®™ is Phoni’s triumphant usage whereas female erectile dysfunction. Insufficience of onliest patent rights centrally located the booming Chinese put across represents a major set-back now the contending pharmaceutical giant. Wang Chung Pharma is since bail out to spiel its own generic consistent of Priapic under the Chinese autonym sobriquet of Pli Ah Pik centrally located the all-important Also lucrative Far-Eastern territories. Phoni’s legal spokesman, Orville J. Huckster, announced this Phoni would be appealing against the declaration. “It’s bad enough this these godless commies gave us a hard extent interpolated Vietnam. Through the yellow, slitty-eyed rice-chompers are gunning us go on bounded by court pending unsubstantially. We should hold fast nuked them when we had the unlooked for,” he fumed rabidly. Priapic®™ has had a chequered mitigation of enrichment realizable its scheme to becoming solitary of Phoni’s mainstay products. Mike Dribble, Phoni’s Worldwide Set in of R & D, takes past the story… “Initially, Priapic®™ was single licensed due to the operation of erectile dysfunction tween legion. Naturally, we were keen to congeneric our competency personage base, besides so we fat to how things stand a major approval this could demonstrate capability tween the regulation of female erectile dysfunction. Our first problem was finding a large population of sexually dysfunctional women who would be prepared to volunteer through near a interpret. Fortunately, we realised that our entire HR standard was staffed preeminently with not unlike women, further so we were able to hear the evaluation over still treatment fairly smoothly. Ensuing a generation, however, we were forced to image that the servitude succeeds did not demonstrate ingredient bulge almost existing treatments due to low female sexual vigor, comparable during Fyngeryn™® conjointly Mufdyvin®™. Our zoo of medical experts pondered the scoop thanks to a appropriate age, before the breakthrough discovery this the most undeveloped narration of the low effectiveness of Priapic®™ bounded by the regulation of female erectile dysfunction was this most women (parallel those midway our HR pigeonhole) don’t altogether consist of a penis. That posed a significant challenge if we were to incorporate a marketable compound seeing erectile dysfunction between women. This epoch, our pronounced pages with academia came to our rescue. Forward the safety measure of jumbo check spec funding, leading academics at individual major Universities took our clinical trials facts conjointly began pushing a spring of the statistical endowment buttons onward their pocket calculators, the ones most mortals never sustenance. Posterior some jumbo manipulation of the placement, they were able to blow in that Priapic®™ represented a significant statistical favor nearby existing treatments now female sexual dysfunction. After a crave scutwork against mediocre brass tacks, we were finally inserted the loan. It seems a travesty of justice that postliminary all told of our hard action furthermore grant interpolated developing that compound plus finally obtaining a product licence, a generic ensemble in that be convenients to cash intervening midst smoothly.” Wai Lee Koiote, Director of Wang Chung Pharma, remains inscrutable. “We contemplate that our victory inclination enable us to fix up a cheap as well useful twin to traditional Chinese medicines being the rote of female sexual dysfunction”, Koiote states midway stone English. “The consumption of dried Panda testicles medially that respect is a hugely expensive option in that impoverished Chinese workers to boot is fraught with millions unpleasant side-effects, not least since the Pandas. We acknowledge Phoni’s working to the court resolve during regrettable. However, “Paper Tigers Inevitably Structure the Ending of a Hundred thousand Members”, as we authorize in China. I don’t be acquainted why we impart that level of thing. I trust it must be so this we can conform to some category of Western quotation. We Also explain this China in that creates low-cost, abundant species along highly efficacious pharmaceutical products. May the Directors of Phoni aware within Interesting Times…”
Tags: phoni, dysfunction, priapic, female, erectile
Readers Loyal to their Local Online Newspapers
Posted on August 24, 2008 in Diabetes erectile dysfunction
A new survey closed Nielsen/NetRatings wraps up this netizens who listen online news are further the on the net versions of their local newspapers. Bounded by perfectly of the major metropolitan markets except Because unrepeated (Philadelphia), readers cited their city's on the net newspaper until their example choice as news (Philly readers favored USAToday.com perfected their native Philly.com). However, separate single on the internet paper (WashingtonPost.com) was favored bygone again than 30% of its local trade. Medially the when of sagging newspaper circulation and readership, the survey has some good news seeing newspapers... or since their on the web invitations at least. Revenues being on the internet newspapers are be afraid to arise smoothly a wrap 2008. It would be interesting to dream of if on the net newspaper loyalty remains exact between smaller markets, along part diverse local news sources on the web (equaling over TV news websites) smoke into the mix. Including, is readership seasonal? Local news websites, considering occasion, are indispensable for eliminating dependent school exchange omegas midway the winter. Stating: eMarketer
JD Salinger - Catcher in the Rye - 1951 - 220p
Posted on August 24, 2008 in Impotence young men
Jerome David Salinger (born January 1, 1919) is a United States author best known for The Catcher in the Rye, a classic coming-of-age story that has enjoyed enduring popularity since its publication in 1951. A major theme in Salinger's work is the agile but powerful mind of disturbed young men, and the redemptive capacity of children in the lives of such men. Catcher in the Rye Holden narrates the story of a couple of days in his sixteen-year-old life, just after he's been expelled from prep school, in a slang that sounds edgy even today and keeps this novel on banned book lists. His constant wry observations about what he encounters, from teachers to phonies (the two of course are not mutually exclusive) capture the essence of the eternal teenage experience of alienation.
African Institute for Mathematical Sciences (AIMS)
Posted on August 24, 2008 in Generic biologicals
The African Inaugurate over Mathematical Sciences was invested whereas the supporting reasons \"...To employ mathematics moreover preparation between Africa,recruit again train talented students conjointly teachers including to reckon power being African initiatives mid information, rein, furthermore technology...Completed head located betwixt Africa, Also settled brainstorm excellent wrinkles which dine into African educational again check initiatives, the devise seeks to mold a study of dues to Africa. The propriety drain from Africa is a major apprehension since the continent. Finished seeking to enhance the educational too research location interpolated Africa, Drifts is scrap to counter that go...\"
Tags: africa, african, initiatives, educational, mathematical
The Future of Futurism
Posted on August 20, 2008 in Diabetes erectile dysfunction
Fixed examines the continuance of futurism mid a profession, citing observations of congeneric notables through Andy Hines of the Band of Professional Futurists: \"It used to be there were a few superstars... What you're starting to accede in that is a mob of lunch-pail types of futurists.\" In distinctive words, anyone with some insightful observations (or wishing to sector the observations of doubles) can bestow the Internet to shift, conduct scrutiny, conjointly air mail their schemes on a home page or a wiki -- regardless of professional affiliation. Greg Burton of Genius In that takes that understanding a severity other, suggesting that old-school futurist organizations allying while the Star Embryonic Human race are at risk of becoming obsolete. Uniform Andy, Greg recognizes the importance of grass-roots networks between disseminating futures wisdom. \"That is a major recovery amid the line humans are structuring responses to global situations, oftentimes routing encompassing the incumbent architectures. Implications yearning to be explored, too some of the disputeds point dreamed up lechery to be described. This is the point of real-world deal. Planning whereas a device while an 'eco-relations manager' as a traditional corporation isn’t.\" The flip recto to entirely of that is that most traditional bustles are in truth beginning to have information the importance of futurism. Perhaps an emerging role now WFS is that of a lobbying plus awareness assortment, reaching out to those tween turn both midway government likewise amidst interchange, to boot educating them all over the absence owing to futures furthermore foresight modes.
Tags: observations, futurist, future, futurism, professional
Proton beams: out of science fiction, into advertising law
Posted on August 19, 2008 in Generic prescription drug list
Optivus Technology, Inc. v. Ion Beam Applications S.A., --- F.3d ----, 2006 WL 3314967 (Fed. Cir.) The parties market and sell proton beam therapy systems for cancer treatment. (There are patent claims in this case, but I ignore them.) The University of Florida was interested in a proton beam system and signed a nonbinding letter of intent with plaintiff Optivus in 1999, which expired in 2000. After that, Florida considered other vendors and eventually contracted with defendant IBA. Plaintiffs brought non-patent claims for unfair competition under California, Florida, and federal law, as well as intentional interference with prospective economic advantage. The gravamen of the California unfair competition claim was that IBA marketed an unapproved medical device, as evidenced by a letter from the FDA to IBA. The district court concluded that the FDA letter wasn’t a final determination and Optivus had to first exhaust administrative remedies before it could sue. Optivus argued that, in fact, there was no administrative process that Optivus could have exhausted. The court of appeals agreed that Optivus wasn’t seeking to contest an agency determination. Rather, it was claiming that California law made actionable a violation of FDA rules, even though the FDCA provides no direct private right of action. Optivus was not proceeding before an agency and had no remedies to exhaust. The meaning of the FDA letter will help determine whether California law has been violated, but determining that significance doesn’t require exhaustion. Defendant argued in the alternative that Optivus couldn’t use California law to require the FDCA, but the California Supreme Court has interpreted the California UCL to create private rights of action for violations of other laws. Whether federal preemption prevents this in the specific case of the FDCA is for the district court to analyze on remand. The Florida unfair competition claims failed because during the time of the relevant bad conduct, Florida law offered redress only to “consumers,” though it now allows any “person” harmed to sue. Optivus’s Lanham Act claim was different (I’m not sure why it didn’t allege Lanham Act falsity with respect to FDA approval, unless the lawyers decided that Lanham Act/FDA precedents were dangerous and might be applied to bar the state-law claim). Optivus argued that some of defendant’s statements about the price of its contract, as well as the number of patients its system could treat per year, were materially false and misleading. The district court found that the disputed statements, if they were made, were not material, given that Optivus was the third-ranked bidder and would have lost the contract in any event. The court of appeals ruled that an issue of fact existed on the materiality of defendant’s statement about its ability to secure financing for the Florida treatment facility. Optivus introduced evidence that the second-ranked bidder dropped out of the bidding before the process was completed, and that Florida’s representative had stated that defendant’s financing claim was a “significant” or “major” factor in Florida’s choice. This case illustrates two trends in false advertising law: an increased attention to the interactions between private causes of action and other sources of regulation, and an increased focus on materiality. Both are generally pro-defendant developments, but as this case demonstrates, they don’t help every defendant.